GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » Cyclically Adjusted PS Ratio

Kyowa Kirin Co (TSE:4151) Cyclically Adjusted PS Ratio : 3.80 (As of May. 26, 2024)


View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co Cyclically Adjusted PS Ratio?

As of today (2024-05-26), Kyowa Kirin Co's current share price is 円2568.00. Kyowa Kirin Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 was 円675.49. Kyowa Kirin Co's Cyclically Adjusted PS Ratio for today is 3.80.

The historical rank and industry rank for Kyowa Kirin Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:4151' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.06   Med: 3.86   Max: 6.85
Current: 3.8

During the past years, Kyowa Kirin Co's highest Cyclically Adjusted PS Ratio was 6.85. The lowest was 2.06. And the median was 3.86.

TSE:4151's Cyclically Adjusted PS Ratio is ranked worse than
72.68% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.11 vs TSE:4151: 3.80

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Kyowa Kirin Co's adjusted revenue per share data for the three months ended in Sep. 2023 was 円198.721. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円675.49 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kyowa Kirin Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Kyowa Kirin Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co Cyclically Adjusted PS Ratio Chart

Kyowa Kirin Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.14 4.01 4.56 5.03 4.60

Kyowa Kirin Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.13 4.60 4.38 4.00 3.85

Competitive Comparison of Kyowa Kirin Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Kyowa Kirin Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyowa Kirin Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Kyowa Kirin Co's Cyclically Adjusted PS Ratio falls into.



Kyowa Kirin Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Kyowa Kirin Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2568.00/675.49
=3.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyowa Kirin Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Kyowa Kirin Co's adjusted Revenue per Share data for the three months ended in Sep. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=198.721/106.2000*106.2000
=198.721

Current CPI (Sep. 2023) = 106.2000.

Kyowa Kirin Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 161.558 95.600 179.471
201403 157.150 95.700 174.392
201406 138.444 98.000 150.028
201409 140.552 98.500 151.539
201412 172.526 97.900 187.153
201503 163.560 97.900 177.427
201506 163.015 98.400 175.937
201509 171.749 98.500 185.175
201512 166.824 98.100 180.598
201603 161.538 97.900 175.233
201606 156.237 98.100 169.137
201609 152.859 98.000 165.649
201612 164.473 98.400 177.510
201703 166.651 98.100 180.411
201706 156.427 98.500 168.655
201709 153.750 98.800 165.266
201712 168.137 99.400 179.639
201803 122.516 99.200 131.161
201806 126.280 99.200 135.191
201809 117.930 99.900 125.367
201812 137.271 99.700 146.220
201903 141.115 99.700 150.315
201906 140.648 99.800 149.668
201909 137.780 100.100 146.176
201912 151.223 100.500 159.800
202003 143.828 100.300 152.288
202006 149.829 99.900 159.278
202009 141.745 99.900 150.684
202012 156.923 99.300 167.827
202103 150.919 99.900 160.436
202106 156.100 99.500 166.611
202109 165.474 100.100 175.558
202112 182.852 100.100 193.995
202203 163.247 101.100 171.482
202206 181.408 101.800 189.249
202209 183.233 103.100 188.742
202212 213.185 104.100 217.486
202303 173.989 104.400 176.989
202306 196.553 105.200 198.421
202309 198.721 106.200 198.721

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kyowa Kirin Co  (TSE:4151) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Kyowa Kirin Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyowa Kirin Co (TSE:4151) Business Description

Traded in Other Exchanges
Address
1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines